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Polo-like kinase 4 controls centriole duplication 
but does not directly regulate cytokinesis
Andrew J. Hollanda,b, Daniele Fachinettia,b,*, Sandrine Da Cruza,b,*, Quan Zhuc, Benjamin Vitrea,b, 
Mariana Lince-Fariad, Denaly Chena,b, Nicole Parisha,b, Inder M. Vermac, Monica Bettencourt-Diasd, 
and Don W. Clevelanda,b
aLudwig Institute for Cancer Research and bDepartment of Cellular and Molecular Medicine, University of California, 
San Diego, La Jolla, CA 92093; cLaboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037; 
dInstituto Gulbenkian de Ciência, P-2780-156 Oeiras, Portugal
ABSTRACT Centrioles organize the centrosome, and accurate control of their number is crit-
ical for the maintenance of genomic integrity. Centrioles duplicate once per cell cycle, and 
duplication is coordinated by Polo-like kinase 4 (Plk4). We previously demonstrated that Plk4 
accumulation is autoregulated by its own kinase activity. However, loss of heterozygosity of 
Plk4 in mouse embryonic fibroblasts has been proposed to cause cytokinesis failure as a pri-
mary event, leading to centrosome amplification and gross chromosomal abnormalities. 
Using targeted gene disruption, we show that human epithelial cells with one inactivated 
Plk4 allele undergo neither cytokinesis failure nor increase in centrosome amplification. Plk4 
is shown to localize exclusively at the centrosome, with none in the spindle midbody. Substan-
tial depletion of Plk4 by small interfering RNA leads to loss of centrioles and subsequent 
spindle defects that lead to a modest increase in the rate of cytokinesis failure. Therefore, 
Plk4 is a centriole-localized kinase that does not directly regulate cytokinesis.
INTRODUCTION
Centrosomes are the major microtubule-organizing center of animal 
cells and play an important role during mitosis, in which they organize 
the poles of the bipolar microtubule spindle upon which chromo-
somes are segregated. Although not strictly essential for the forma-
tion of the meiotic/mitotic spindle, whenever they are present cen-
trosomes play a dominant role in guiding spindle formation (Nigg 
and Raff, 2009; Debec et al., 2010). Extra copies of centrosomes 
(referred to as centrosome amplification) lead to the formation of mul-
tipolar mitotic spindles, which, after centrosome clustering, enrich for 
inappropriate kinetochore–microtubule interactions, promoting chro-
mosome missegregation (Ganem et al., 2009; Silkworth et al., 2009). 
Centrosome amplification is frequently observed in aneuploid human 
tumors, where it is proposed to play a causative role in genome insta-
bility and tumor development (Nigg, 2006). One pathway by which 
cells may acquire extra centrosomes is through a failure of cytokinesis, 
resulting in the production of tetraploid cells with twice the normal 
centrosome number (Meraldi et al., 2002; Holland and Cleveland, 
2009). Indeed, tetraploidy often precedes the development of aneu-
ploidy and has been shown to promote cellular transformation and 
tumor formation in murine cells lacking p53 (Fujiwara et al., 2005).
A centrosome is comprised of two centrioles that recruit a pro-
teinaceous matrix called the pericentriolar material (PCM; Tsou and 
Stearns, 2006; Loncarek and Khodjakov, 2009). Because the centri-
oles recruit the PCM and determine the number of centrosomes in 
the cell, centrosome duplication is coupled to centriole duplication. 
A centriole pair duplicates once per cell cycle before mitosis to cre-
ate two centrosomes before mitotic entry. In vertebrates and inver-
tebrates the protein kinase Polo-like kinase 4 (Plk4) plays an essen-
tial role in controlling centriole duplication; in the absence of Plk4, 
centriole duplication fails, whereas elevated levels of Plk4 lead 
to the formation of multiple centrioles in a single cell cycle 
(Bettencourt-Dias et al., 2005; Habedanck et al., 2005; Kleylein-
Sohn et al., 2007; Peel et al., 2007). Determining how the level 
and activity of Plk4 are controlled during the cell cycle is critical for 
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Plk4 through the F-box protein β-TrCP 
(Cunha-Ferreira et al., 2009; Rogers et al., 
2009; Guderian et al., 2010; Holland et al., 
2010). Plk4 stability is linked to the activity of 
the enzyme, with active Plk4 phosphorylat-
ing itself to promote its own destruction 
(Guderian et al., 2010; Holland et al., 2010; 
Brownlee et al., 2011). This creates a feed-
back loop that regulates the cellular levels 
of Plk4 (Holland et al., 2010).
Surprisingly, Plk4 heterozygous mice 
have been reported to exhibit centrosome 
amplification and an increased incidence of 
spontaneous lung and liver tumors (Ko et al., 
2005). Murine embryonic fibroblasts (MEFs) 
derived from Plk4+/− animals were reported 
to undergo cytokinesis failure after several 
passages in culture, leading to an enrich-
ment of cells with a (near) tetraploid DNA 
content (Rosario et al., 2010). Consistent 
with the generation of tetraploid cells, these 
Plk4+/− MEFs were also reported to exhibit 
elevated levels of centrosome amplification, 
and late-passage MEFs formed tumors 
when injected into nude mice. The cytoki-
netic defect observed in Plk4+/− MEFs led to 
the proposal that Plk4 directly regulates cy-
tokinesis by localizing to the spindle mid-
body, where it activates RhoA through regu-
lation of the RhoA guanine exchange factor 
Ect2 (Rosario et al., 2010). However, it is un-
clear whether Plk4 protein levels are re-
duced in Plk4+/− cells and, if so, how a partial 
reduction in the level of Plk4 could directly 
lead to a failure of cytokinesis.
Using targeted gene disruption in RPE1 
cells, we demonstrate here that heterozy-
gosity of Plk4 leads to only a slight reduction 
in the level of centrosome-associated Plk4, 
consistent with self-regulation of the level of 
the centrosome-localized kinase (Holland 
et al., 2010). More important, Plk4+/− human 
and mouse cells do not undergo cytokinesis 
failure or exhibit an increase in centrosome 
amplification. We show Plk4 to be localized 
exclusively to the centrosome, with none 
accumulated in the spindle midbody. Deple-
tion of Plk4 by small interfering RNA (siRNA) 
leads to loss of centrioles and subsequent 
spindle defects that indirectly lead to a 
modest increase in the rate of cytokinesis 
failure. We thus propose that Plk4 is a centri-
ole-localized kinase that does not directly 
regulate cytokinesis.
RESULTS AND DISCUSSION
To study the effect of loss of a single allele of 
Plk4, we used gene targeting to insert a 
transcriptional/translational stop cassette into intron 4 (null allele 1) 
or 5 (null allele 2) of the endogenous Plk4 gene in telomerase-im-
mortalized human RPE1 cells (Figure 1, A and B). The transcriptional/
translational stop cassette prevents transcription and translation 
a better mechanistic understanding of how the correct number of 
centrioles and centrosomes is maintained in animal cells.
Plk4 is a low-abundance protein and is targeted for destruction 
by the Skp/Cullin/F-box E3 ligase, which binds to phosphorylated 
FIGURE 1: Generation of heterozygous Plk4 human cells. (A) Schematic showing the targeting 
strategy used to create a Plk4-null allele in RPE1 cells. A splice acceptor and a transcriptional/
translational stop cassette were introduced into intron 4 of the endogenous human Plk4 gene 
by homologous recombination. (B) As in A, except that the splice acceptor and a transcriptional/
translational stop cassette were inserted into intron 5. (C) Quantitative RT-PCR analysis of Plk4 
mRNA levels in Plk4+/+ and Plk4+/− RPE1 cell lines. mRNA levels were calculated from two 
independent sets of Plk4 primers and normalized to two standard genes. Bars represent the 
mean of six independent replicas, and error bars represent the SEM. (D) Immunofluorescence 
images show representative Plk4 levels at the centrosome of Plk4+/+ and Plk4+/− RPE1 cell lines. 
Red, γ-tubulin; green, Plk4; blue, DNA. Scale bar, 5 μm. Graph shows quantitative 
immunofluorescence analysis of Plk4 protein levels at the centrosome of Plk4+/+ and Plk4+/− 
RPE1 cell lines. Bars show the mean of >32 cells per condition from three independent 
experiments. Error bars represent the SEM.
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was used to demonstrate that Plk4+/− 1 and 
2 cells (each of which carries a single undis-
rupted copy of the Plk4 gene) have a ∼50% 
reduction in Plk4 mRNA compared with 
nontargeted control cells (Figure 1C). Plk4 is 
a low-abundance protein and, consistent 
with previous reports, we were unable to 
detect expression of the endogenous pro-
tein by immunoblotting (Supplemental 
Figure S1A). We therefore used quantitative 
immunofluorescence to determine the level 
of Plk4 protein at the centrosome of Plk4+/+ 
and Plk4+/− cells. An antibody raised against 
the C-terminus of the human Plk4 protein 
(amino acids 510–970) detected a cen-
trosome-localized signal by immunofluores-
cence (Supplemental Figure S1B). This sig-
nal was specific for Plk4, as transfection with 
a pool of siRNAs targeting Plk4 resulted in 
dramatic reduction in the level of centro-
some staining (see Figure 4C later in the 
paper). Despite ∼50% reduction in mRNA, 
Plk4+/− cells showed <20% reduction in the 
level of Plk4 protein localized to the cen-
trosome, suggesting that Plk4 heterozygos-
ity does not lead to haploid levels of the 
centrosome-associated kinase (Figure 1D).
After >30 passages in culture, Plk4+/− 
RPE1 cells showed no evidence of cen-
trosome amplification or increase in cellular 
ploidy (Figure 2A). Moreover, when com-
pared with Plk4+/+ cells, Plk4+/− cells grew at 
the same rate, exhibited similar clonogenic 
survival, and showed no increase in the frac-
tion of aneuploid cells (Figure 2, B–D). The 
tumor suppressor protein p53 has been im-
plicated in suppressing the proliferation of 
polyploid cells, and removal of p53 was re-
ported to increase the fraction of tetraploid 
Plk4+/− MEFs (Rosario et al., 2010). Never-
theless, depletion of p53 to undetectable 
levels with a constitutive short hairpin RNA 
(shRNA) did not yield an increase in the frac-
tion of polyploid Plk4+/+ or Plk4+/− RPE1 cells 
(Figure 2, E and F). Of interest, p53 deple-
tion resulted in centrosome amplification in 
∼15–20% of both Plk4+/+ and Plk4+/− cells, 
possibly reflecting a role of p53 in regulat-
ing centriole duplication (Tarapore et al., 
2001; Shinmura et al., 2007).
Because we were unable to observe a 
phenotypic consequence of Plk4 heterozy-
gosity in human RPE1 cells, we reexamined 
the reported cytokinetic defects in Plk4+/− 
MEFs that were obtained from the authors 
of a previous study (Rosario et al., 2010). 
Use of quantitative RT-PCR revealed that Plk4+/− MEFs had close to 
a 50% reduction in Plk4 mRNA; however, quantitative immunofluo-
rescence showed this resulted in <10% reduction in the level of Plk4 
protein associated with the centrosome (Figure 3, A and B). More-
over, in contrast with previous reports, we were unable to find any 
evidence of elevated centrosome amplification or polyploidization 
downstream of exon 4 (for null allele 1) or exon 5 (for null allele 2) of 
the Plk4 gene. Because exon 6-16 of Plk4 contains sequences re-
quired for Plk4 recruitment to the centriole and ability to promote 
centriole duplication, any truncated protein product translated from 
null allele 1 or 2 would strongly be expected to be nonfunctional 
(Leung et al., 2002; Habedanck et al., 2005). Quantitative RT-PCR 
FIGURE 2: Plk4+/– human cells do not undergo cytokinesis failure and show no increase in the 
level of centrosome amplification or aneuploidy. (A) Representative flow cytometry profiles of 
Plk4+/+ and Plk4+/− RPE1 cells. Numbers at the top right indicate the mean level of centrosome 
amplification from three independent experiments. (B) To monitor growth rate, Plk4+/+ and 
Plk4+/− RPE1 cells were counted every 2 d. Values represent the mean of two independent 
experiments, and error bars represent the SEM. (C) Graph shows the fraction of cells with 46 
chromosomes in Plk4+/+ and Plk4+/− RPE1 cell lines. Bars represent the mean of >27 cells per 
condition from three independent experiments. Error bars represent the SEM. 
Immunofluorescence images show representative chromosome spreads from the indicated cell 
lines. (D) The percentage clonogenic survival for the Plk4+/+ and Plk4+/− RPE1 cell lines. Bars 
represent the mean of at least two independent experiments. Error bars represent the SEM. 
Images show representative crystal violet–stained colonies for the indicated cell lines. 
(E) Immunoblot of UV-irradiated Plk4+/+ and Plk4+/− RPE1 cells stably expressing a p53 shRNA. 
(F) Representative flow cytometry profiles of Plk4+/+ and Plk4+/− RPE1 cells stably expressing a 
p53 shRNA. Numbers at the top right indicate the mean level of centrosome amplification from 
two independent experiments.
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overexpressed enhanced yellow fluorescent 
protein (EYFP)–tagged Plk4 transgene also 
localized to the centrosome, with none at 
the spindle midbody (Figure 4B).
Because heterozygosity of Plk4 does not 
substantially reduce the level of centrosome-
bound Plk4 (Figure 1, C and D), we carefully 
reexamined the phenotype(s) caused by 
substantial depletion of Plk4 with small inter-
fering RNA (siRNA). Quantitative immuno-
fluorescence showed Plk4 levels at the cen-
trosome were reduced by >75% at 2 d after 
depletion of Plk4 by siRNA. This is an under-
estimate of the level of Plk4 depletion, as 
we were only able to quantify centrosome-
localized Plk4 levels in cells with at least one 
centrosome, and 39% of Plk4 depleted cells 
contained no centrosomes at 2 d after de-
pletion (Figure 4D). Staining with γ-tubulin 
antibodies to monitor centrosomes revealed 
that 86% of control siRNA cells showed two 
γ-tubulin foci, whereas 92% of cells depleted 
of Plk4 contained one or no γ-tubulin foci 
(Figure 4D). Analysis of mitotic figures re-
vealed that control siRNA-treated cells ex-
hibited normal bipolar spindles with two 
centrioles at each pole (Figure 4E). By con-
trast, depletion of Plk4 resulted in a number 
of mitotic spindle abnormalities: 48 h after 
Plk4 depletion a minority of cells had only a 
single centriole at each pole of a bipolar 
spindle, and many cells possessed only a 
single centriole at one pole (Figure 4E). In 
these cells the spindle was asymmetrically 
shaped, with the poorly focused acentriolar 
pole lacking astral microtubules and having 
a shorter half-spindle length (Figure 4E). In 
some cases, the acentriolar pole was multi-
polar, and occasionally aberrant spindles 
lacking centrioles altogether were observed 
(Figure 4E). Thus, consistent with previous 
reports, cells depleted of Plk4 undergo a 
stepwise loss of centrioles but continue to 
cycle (Bettencourt-Dias et al., 2005; Habe-
danck et al., 2005).
To establish whether substantial Plk4 
depletion resulted in a failure of cytokinesis, 
we used time-lapse microscopy to follow 
mitotic divisions in Plk4-depleted RPE1 cells 
coexpressing EYFP–α-tubulin and histone H2B–monomeric red flu-
orescent protein (RFP). Ninety-eight percent of cells treated with 
control siRNA progressed through mitosis normally, with an average 
time of 31 min (Figure 5, A–C, and Supplemental Movie S1). How-
ever, 73% of cells depleted of Plk4 divided abnormally and delayed 
in mitosis, taking on average 69 min to divide. The vast majority 
(93%) of the Plk4-depleted cells that behaved abnormally divided in 
a bipolar manner with an asymmetric spindle containing one acen-
triolar pole (Figures 5A, yellow arrow, and 5D and Supplemental 
Movie S2).
However, in a small fraction of cells (3%) the poorly focused acen-
triolar pole split into two, causing a multipolar division (Figures 5A, 
yellow arrow, and 5D and Supplemental Movie S4). Plk4-depleted 
in Plk4+/− MEFs, even after a prolonged period in culture (Figure 3, 
C and D). Taken together, our data demonstrate that heterozygosity 
of Plk4 does not lead to polyploidization and centrosome amplifica-
tion in mouse or human cells.
We next reexamined the reported localization of Plk4 to the spin-
dle midbody, where it has been proposed to control the activity of 
RhoA to directly regulate cytokinesis (Rosario et al., 2010). As ex-
pected, staining with our Plk4 antibody revealed that endogenous 
Plk4 was localized at centrosomes of human cells; however, mid-
body staining was never observed (Figure 4A). This is consistent 
with a previous study that also reported an inability to detect 
midbody associated Plk4 (Habedanck et al., 2005). This lack of Plk4 
midbody staining was not due to epitope masking, because an 
FIGURE 3: Plk4+/– MEFs show no evidence of cytokinesis failure or increased levels of 
centrosome amplification after a prolonged duration in culture. (A) Quantitative PCR analysis 
of Plk4 mRNA levels in Plk4+/+ and Plk4+/− MEFs. mRNA levels were calculated from five 
independent sets of Plk4 primers and normalized to two standard genes. Bars represent 
the mean of three independent replicas, and error bars represent the SEM. 
(B) Immunofluorescence images show representative Plk4 levels at the centrosome of Plk4+/+ 
and Plk4+/− MEFs. Red, γ-tubulin; green, Plk4; blue, DNA. Scale bar, 5 μm. Graph shows the 
quantitative immunofluorescence analysis of Plk4 protein levels at the centrosome of the 
indicated cells. Bars show the mean of >146 cells per condition from three independent 
experiments. Error bars represent the SEM. (C) PCR genotyping of passage 3 (P3) and 
passage 10 (P10) Plk4+/+ and Plk4+/− MEFs. (D) Representative flow cytometry profiles of 
Plk4+/+ and Plk4+/− MEFs at various passages after derivation. Experiments were performed 
twice on two independent Plk4+/+ and Plk4+/− MEF cell lines. Numbers on the left indicate the 
passage number (P) and the days (d) cells were in culture when analysis was performed. 
Numbers at the top right indicate the mean level of centrosome amplification from two 
independent experiments.
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Thus, we have demonstrated that a sub-
stantial reduction in Plk4 protein levels re-
sults in loss of centrioles, confirming the es-
sential role of Plk4 in centriole duplication 
(Bettencourt-Dias et al., 2005; Habedanck 
et al., 2005). Cytokinesis failure, however, is 
seen only as an indirect consequence of the 
spindle abnormalities caused by loss of cen-
trioles following loss of Plk4.
MATERIALS AND METHODS
Cell culture
hTERT RPE-1 and DLD-1 cells were main-
tained at 37°C in a 5% CO2 atmosphere with 
21% oxygen. hTERT RPE-1 cells were grown 
in DMEM:F12 medium containing 10% 
tetracycline-free fetal bovine serum (FBS; 
Clontech, Mountain View, CA), 0.348% so-
dium bicarbonate, 100 U/ml penicillin, 
100 U/ml streptomycin, and 2 mM l-glu-
tamine, whereas Flp-In TRex-DLD-1 cells 
were grown in DMEM containing 10% tetra-
cycline-free FBS (Clontech), 100 U/ml peni-
cillin, 100 U/ml streptomycin, and 2 mM 
l-glutamine. Primary MEFs were grown in 
DMEM supplemented with 15% FBS, 
0.1 mM nonessential amino acids (Life 
Technologies, Carlsbad, CA), 1 μM 2-mer-
captoethanol (Specialty Media, Phillipsburg, 
NJ), 1 mM sodium pyruvate (Life Technolo-
gies), 2 mM glutamine, and 50 μg/ml peni-
cillin/streptomycin in a 37°C humidified 
incubator with 10% CO2 and 3% oxygen. 
Low-oxygen conditions were used to extend 
the cycling time of the primary cells 
(Parrinello et al., 2003). RPE-1 cells were 
used in all experiments except in Figure 3, 
where MEFs were used, and Figure 4B, 
where DLD-1 cells were used.
Gene targeting
To generate the Plk4-null allele 1 and 2 tar-
geting construct, a transcriptional/transla-
tional stop unit was created by gene syn-
thesis (GenScript, Piscataway, NJ) and 
inserted into the pBluescript derivative 
pNY to create a loxP-STOP-neoR-loxP cas-
sette. The transcriptional/translational stop 
is composed of the human adenovirus type 
3/5 splice acceptor, 849 base pairs of the 
SV40 polyadenylation signal region, and a translation initiation sig-
nal followed by an in-frame stop codon and a 5′ donor splice site. 
Taq polymerase (Invitrogen, Carlsbad, CA) was used to amplify 
fragments of the human Plk4 locus from genomic RPE1 DNA. Er-
ror-free clones were identified or created by QuikChange site-di-
rected mutagenesis (Agilent Technologies, Santa Clara, CA), and 
5′ and 3′ arms were PCR amplified and cloned on either side of a 
central loxP-STOP-neoR-loxP cassette in pNY. The entire insert was 
then excised via NotI digestion and ligated to the pAAV vector 
backbone. The final construct was fully sequenced to verify its 
integrity. Procedures for preparation of infectious AAV particles, 
transduction of hTERT RPE1 cells, and isolation of properly 
cells also occasionally formed ectopic tubulin foci that were not in-
corporated into the spindle. In 19% of abnormally dividing Plk4-
depleted cells, these ectopic foci acted as microtubule organizing 
centers and resulted in chromosome missegregation (Figure 5A, 
white arrowhead, and Supplemental Movie S3). However, despite 
the mitotic spindle abnormalities caused by the loss of centrioles, 
88% of abnormally dividing cells depleted of Plk4 underwent nor-
mal cytokinesis and completed abscission (Figure 5D). Of impor-
tance, the 12% of Plk4-depleted cells that failed cytokinesis did so 
likely as a result of mitotic spindle abnormalities or chromosome 
missegregation events that resulted in chromatin left in the cleavage 
furrow.
FIGURE 4: Repression of Plk4 by siRNA results in the loss of centrioles due to impaired 
duplication. (A) Representative immunofluorescence images showing the localization of 
endogenous Plk4 in late-telophase cells. Red, α-tubulin; green, Plk4; blue. Scale bar, 5 μm. 
(B) As in A, except that cells stably overexpressing Plk4-EYFP were used. Red, α-tubulin; green 
Plk4-EYFP; blue, DNA. Scale bar, 5 μm. (C) Representative immunofluorescence images showing 
the level of Plk4 at the centrosome 48 h after transfection of Plk4+/− RPE1 cells with Plk4 or 
GAPDH siRNA. Red, γ-tubulin; Green, Plk4; Blue, DNA. Scale bar = 5 μm. Graph shows the 
quantitative immunofluorescence analysis of Plk4 protein levels at the centrosome 48 h after 
cells were transfected with Plk4 or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
siRNA. Note that only cells with at least one centrosome were quantified in this analysis, and 
thus the level of Plk4 repression is likely to be underestimated. Bars show the mean of >42 cells 
per condition from two independent experiments. Error bars represent the SEM. (D) The 
fraction of Plk4+/− RPE1 cells with the indicated number of γ-tubulin foci 48 h after transfection 
with Plk4 or GAPDH siRNA. Bars show the mean of >180 cells per condition from three 
independent experiments. Error bars represent the SEM. (E) Representative 
immunofluorescence images show phenotypes observed in mitotic Plk4+/− RPE1 cells 48 h after 
transfection with Plk4 or GAPDH siRNA. Red, α-tubulin; green, centrin; blue, DNA. Scale bar, 
5 μm.
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aldehyde-3-phosphate dehydrogenase 
(5′-UGGUUUACAUGAUCCAAUA-3′) were 
purchased from Dharmacon (Lafayette, 
CO). Cells were processed for immunofluo-
rescence microscopy or live-cell imaging 
48 h after transfection.
Antibody production
A C-terminal Plk4 fragment (amino acids 
510–970) was cloned into a pET-23b bacte-
rial expression vector (Novagen, EMD4Bio-
sciences, Gibbstown, NJ) containing a C-
terminal hexahistidine tag. Recombinant 
protein was purified from Escherichia coli 
using Ni–nitrilotriacetic acid beads (Qiagen, 
Valencia, CA) and used for immunization 
(Moravian Biotechnology, Brno, Czech 
Republic)
Antibody techniques
For immunoblot analysis protein samples 
were separated by SDS–PAGE, transferred 
onto nitrocellulose membranes (Bio-Rad, 
Hercules, CA), and then probed with DM1A 
(mouse anti–α-tubulin, 1:5000) Plk4 (rabbit, 
1:500), or p53 (mouse, 1:100; Calbiochem, 
La Jolla, CA) antibody. Immunofluorescence 
was performed as previously described 
(Holland et al., 2010) using the following 
antibodies: GTU-88 (mouse anti–γ-tubulin, 
1:250; Abcam, Cambridge, MA), Plk4 
(rabbit, 1:250), DM1A (mouse anti–α-tubulin, 
1:1000), and centrin (mouse, 1:1000; a kind 
gift of Jeffrey Salisbury, Mayo Clinic Founda-
tion, Rochester, MN). YFP was visualized di-
rectly using a GFP filter set. Immunofluores-
cence images were collected using a 
Deltavision Core system (Applied Precision, 
Issaquah, WA) controlling an interline 
charge-coupled device (CCD) camera (Cool 
Snap, Roper Scientific Photometrics, Photo-
metrics, Tucson, AZ). Images were collected 
using a 100×, 1.4 numerical aperture (NA), 
or a 60×, 1.4 NA, oil objective at 0.2 μm z-sections and subsequently 
deconvolved. Maximum-intensity two-dimensional (2D) projections 
were assembled for each image using softWoRx (Applied Precision). 
For quantification of Plk4 signal intensity, undeconvolved 2D maxi-
mum-intensity projections were saved as unscaled 16-bit TIFF 
images and signal intensities determined using MetaMorph 
(Molecular Devices, Sunnyvale, CA). A 20 × 20 pixel box and a larger 
25 × 25 pixel box was drawn around the centrosome (marked with 
γ-tubulin staining). Integrated Plk4 intensity in the smaller box was 
calculated by subtracting the mean fluorescence intensity in the 
area between the two boxes (mean background) from the mean 
Plk4 intensity in the smaller box and multiplying by the area of the 
smaller box.
Live-cell microscopy
Cells were seeded into 35-mm, poly-l-lysine–coated glass-bottom 
culture dishes (MatTek) and 24 h later transferred to CO2-indepen-
dent media supplemented with 10% FBS, 100 U/ml penicillin, 100 U 
U/ml streptomycin, and 2 mM l-glutamine. For bulk population 
targeted clones was performed as described previously (Berdougo 
et al., 2009).
Generation of stable cell lines and shRNA/siRNA treatment
RFP-tagged histone H2B (H2B-mRFP) and EYFP-tubulin was intro-
duced into Plk4+/− RPE1 cells using retroviral delivery as described 
previously (Shah et al., 2004). Stable integrates were selected in 
5 μg/ml puromycin and 10 μg/ml blasticidin S and single clones 
isolated using fluorescence-activated cell sorting (FACSVantage; 
Becton Dickinson, Franklin Lakes, NJ). A p53 shRNA was introduced 
into cells using lentiviral delivery and single clones isolated using 
fluorescence activated cell sorting (Tiscornia et al., 2003). For siRNA 
treatment, 1.5 × 105 cells were plated in a six-well plate or 35-mm 
poly-l-lysine–coated glass bottom culture dishes (MatTek, Ashland, 
MA) and duplexed siRNAs introduced using Lipofectamine 
RNAiMax (Invitrogen). A pool of four siRNAs directed against Plk4 
5′-GAAAUGAACAGGUAUCUAA-3′, 5′-GAAACAUCCUUCUAUC-
UUG-3′, 5′-GUGGAAGACUCAAUUGAUA-3′, and 5′-GGACCUUA-
UUCACCAGUUA-3′) and a single siRNA directed against glycer-
FIGURE 5: Depletion of Plk4 by siRNA does not result in a primary cytokinesis defect. 
(A) Time-lapse images of Plk4+/− RPE1 cells stably expressing histone H2B-mRFP (red) and 
EYFP-tubulin (green). Filming began 48 h after transfection with Plk4 or GAPDH siRNA. 
Numbers at the top left refer to the time in minutes after nuclear envelope breakdown (NEBD). 
White arrows show the position of normal spindle poles, and yellow arrows mark the position of 
acentriolar spindle poles (Figure 4C). White arrowhead marks the position of an ectopic, 
acentriolar bundle of microtubules, which attach to and lead to the missegregation of a small 
number of chromosomes. (B) Quantification of the proportion of cells dividing normally or 
abnormally in time-lapse movies of Plk4 or GAPDH siRNA–transfected Plk4+/− RPE1 cells. Cells 
were filmed for 48 h beginning 24 h after transfection with siRNA. Bars show the mean of 
>241 cells per condition from two independent experiments. Error bars represent the SEM. 
(C) The time from NEBD to anaphase for the cells filmed in A. Line represents the mean. 
(D) Graphs quantifying the proportion of abnormal Plk4 siRNA–transfected cells exhibiting the 
indicated phenotypes. Bars show the mean of two independent experiments. Error bars 
represent the SEM.
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CGC TTT C-3′; mouse Plk4-5, reverse, 5′-TGA ACC CAC ACA GCT 
CCG CTA G-3′.
analysis, cells were maintained at 37°C in an environmental control 
station and images collected using a Deltavision RT system with a 
40×, 1.35 NA, oil lens at 5-min time intervals. For each time point, 
4 × 3 μm z-sections were acquired for GFP and RFP and maximum-
intensity projection created using softWoRx (Applied Precision).
For high-resolution spinning-disk fluorescence microscopy, cells 
were imaged using a 60×, 1.4 NA, Plan Apochromat oil lens on a 
spinning disk confocal mounted on a Nikon (Melville, NY) TE2000-E 
inverted microscope equipped with a solid-state laser combiner 
(ALC)—491- and 561-nm lines—a Yokogawa CSU10 head, and a 
CCD Clara camera (Andor Technology, South Windsor, CT). Acquisi-
tion parameters, shutters, and focus were controlled by iQ 1.10.0 
software (Andor Technology). The 5 × 2 μm z-sections were acquired 
at 5-min time intervals for GFP and RFP and maximum-intensity pro-
jection created using MetaMorph. Movies were assembled and ana-
lyzed using QuickTime (Apple, Cupertino, CA).
Cell biology
To prepare cells for flow cytometry, cell pellets were fixed in cold 
70% EtOH for 24 h, washed once in PBS, and suspended in PBS 
supplemented with 10 μg/ml RNase A and 50 μg/ml propidium io-
dide. Samples were incubated at room temperature for 30 min and 
analyzed on a flow cytometer (LSRII; BD Biosciences, San Diego, CA). 
Chromosome spreads were carried out as previously described 
(Holland and Taylor, 2006). For clonogenic assays 500 cells were 
seeded in a 10-cm2 culture dish and left to grow for ∼2 wk until colo-
nies were visible by eye. Cells were fixed in methanol for 10 min at 
room temperature and colonies stained with crystal violet (Sigma-
Aldrich, St. Louis, MO). The percentage clonogenic survival was 
determined by dividing the number of colonies formed by the num-
ber of cells initially seeded in the dish.
Quantitative real-time PCR
Total RNA was extracted from cell pellets using TRIzol (Invitrogen) 
and cDNA generated using random hexamers and Superscript III 
reverse transcriptase (Invitrogen) according to the manufacturer’s 
instructions. Quantitative real-time PCR for mouse and human Plk4 
was performed using the iQ SYBR green supermix (Bio-Rad) on the 
IQ5 multicolor real-time PCR detection system (Bio-Rad). Analysis 
was performed using the IQ5 optical system software (version 2.1, 
Bio-Rad). All reactions were carried out in duplicate using two or five 
independent sets of primers for human or mouse Plk4, respectively, 
and expression values were normalized to two control genes: either 
TATA box–binding protein (TBP) and eukaryotic elongation factor 1 
(EEF1) for human cells or actin gamma 1 (ACTG1) and cyclophilin for 
mouse cells. The fold changes in mRNAs expression were calculated 
as previously described (Pfaffl, 2001), and expression values were 
expressed as a percentage of the average expression of the Plk4+/+ 
cells. The following primers were used: human Plk4-1, forward, 5′- 
GGT GGT AGA GGT TTT CCT CTT GC-3′; human Plk4-1, reverse, 
5′-CAG CAC CAG GAG AAT TCT CC ATC-3′; human Plk4-2, for-
ward, 5′-CCT AAG GCC TTA TCA CCT CCT CC-3′; human Plk4-2 
reverse, 5′-CTG AAC CCA CAC AGC TCC ACT AG-3′; mouse Plk4-
1, forward, 5′-GGA GAG GAT CGA GGA CTT TAA GG-3′; mouse 
Plk4-1, reverse, 5′-CCA GTG TGT ATG GAC TCA GCT C-3′; mouse 
Plk4-2, forward, 5′-GTG CAT CGG GGA GAG GAT CGA-3′; mouse 
Plk4-2, reverse, 5′-CAA GAC AGA GGG GTG TTT CAA CTG-3′; 
mouse Plk4-3, forward, 5′- GTG CTT CAG ATA TCG AGT GAT GGG-
3′; mouse Plk4-3, reverse, 5′- GGA AGC ATA CTG ATA TTT CCG 
CCA G-3′; mouse Plk4-4, forward, 5′-GGA CCA TGC TAA TGA 
GGG TCA C-3′; mouse Plk4-4, reverse, 5′-GAA AGC GGC ACT ATT 
CAC GCT C-3′; mouse Plk4-5, forward, 5′-GAG CGT GAA TAG TGC 
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